Aon (AON) delivered mixed results for Q4 2024 as adjusted EPS beat, but revenue missed Wall Street expectations. The ...

General Dynamics presents a compelling value opportunity amid recent share price weakness, despite strong operational ...

Wizz Air stock fell due to Q3 results, revised 2025 outlook, and fleet plan, highlighting high-risk but potentially ...

Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...

Flagstar Financial’s turnaround efforts drive a 15.2% surge. Read why FLG stock is a speculative buy with potential for ...

Google's near-term potential looks bright. Click here to read more on how AI can help improve the outlook for GOOGL stock.

The copper market enters 2025 with even more uncertainty than usual. How is our copper exposure looking? Click here to find ...

Despite risks like geopolitical tensions and high capital expenses, TSMC's long-term vision and market leadership make it a ...

The Western US solar fleet is amid rapid growth, with the region being home to four of the top five markets in planned ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful ...

We admit to being miffed by Enovix's continued volatility. So why do we say we expect big things in the future? Click here to ...